Lataa...
Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma
CD44 is involved in malignant processes including cell motility, tumor growth and angiogenesis. To explore the potential role of CD44 as a prognostic biomarker in low grade gliomas (LGG), the mRNA expression levels of CD44 in tissues from 12 patients with glioma were evaluated by microarray analysis...
Tallennettuna:
| Julkaisussa: | Oncol Lett |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6732950/ https://ncbi.nlm.nih.gov/pubmed/31516582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10728 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|